Subscribe to Blog via Email
The term invisible illness refers to any medical condition that is not outwardly visible to others, even healthcare professionals. Invisible illnesses encompass a broad range of conditions, including heart disease, diabetes, dementia, psychiatric illness, autoimmune disorders, and even cancer.
Many Neuroendocrine Cancer patients look outwardly healthy, and this can often lead to a lack of appreciation of the potential dangers lurking in their life, the person’s actual capabilities, and how they cope with their condition.
I am sure those reading who have a Neuroendocrine Cancer diagnosis will find something similar to their own experiences.
Growing invisibly inside me for years before making a vague announcement
I had no idea the cancer was growing in me for years. Perhaps some of my routine illnesses weren’t as routine as I thought. Sorry too late, I’m metastatic, and up to 50% of patients (depending on primary location) will be at diagnosis (so I’m not alone!). It’s very SNEAKY!
The fibrosis in my retroperitoneal cavity can’t be seen
I really didn’t know what to make of this issue at diagnosis, although I did know the aorta was pretty important! Fortunately, I had a surgeon who had operated on many NET patients and had seen this issue before. After my first surgery, he described it as a “dense fibrotic retroperitoneal reaction encircling his aorta and cava (inferior vena cava (IVC))”. My surgeon was known for difficult and extreme surgery, so as part of the removal of my primary, he also spent 3 hours dissecting the retroperitoneal fibrosis surrounding these important blood vessels and managed 270-degree clearance. The remnant still shows on CT scans. Some of the removed tissue was tested and found to be benign, showing only florid inflammation and fibrosis (thankfully). That said, the abstract papers above have led me to believe that my retroperitoneal fibrosis is clinically significant. In fact, I have spent the last 3 months worrying about some of it growing into the reach of important vessels and only just been given the all-clear (for now).
Oversecreting hormones (Syndromes) can also be invisible
There are many hormones involved with Neuroendocrine Cancer which is unique in that different types can result in elevated levels of different hormones, often more than one is involved. Serotonin has caused fibrosis in my retroperitoneal area and is currently threatening important vessels. I don’t really need that right now!
Ongoing symptoms and side effects in competition with regular illness
I was showing symptoms of a Neuroendocrine Cancer syndrome known as Carcinoid Syndrome (currently) such as flushing and diarrhea and fatigue was probably there too, but these were thought to be something else or ignored (by me). I don’t suffer too much nowadays other than the side effects of the disease or the treatment I’ve had or received. However, I know from speaking to many patients that the effects of the various syndromes associated with Neuroendocrine Cancer can be pretty debilitating and oppressive to quality of life. But much of this is handled inside closed doors. You would not know if you bumped into this person in a shopping complex or cinema or holiday resort.
These syndromes can be so strange and so weird, that they can be very difficult for patients, nurses, and doctors to treat. They can be a real ‘witch’s brew’.
I might have succumbed to hypothyroidism – that’s invisible too
Another pill for life. I have a left-sided thyroid lesion and my treatment also messes with my hormone levels. But you wouldn’t know to look at me.
But I have a lot of be thankful for
Sometimes it isn’t slow-growing, particularly for high-grade cases. But this invisibility can also be applied to high grades, even poorly differentiated cases. I will continue to advocate for those types too:
You may also enjoy these similar and related articles:
Things not to say to a cancer patient – click here
Shame on you! – click here
Things are not always how they seem – click here
Not every illness is visible – click here
Not the stereotypical picture of sick – click here
An Ode to Invisible Illness – click here
You must be doing OK, you’ve not had chemotherapy – click here
I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.
Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional.
Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.
Subscribe to Blog via Email
Top 10 Posts & Pages in the last 48 hours (auto updates) (Click the titles to read them)
Thanks for reading.
Sign up for my newsletters – Click Here
Check out my Glossary of Terms – click here
Please Share this post for Neuroendocrine Cancer awareness and to help another patient
What is Carcinoid Syndrome? Carcinoid syndrome (CS) is the most frequent hormonal complication accompanying neuroendocrine neoplasms (NENs) and is defined by chronic diarrhoea and/or flushing in the
I was delighted to see this clinical trial which looks at the efficacy of PRRT (Lu177) vs the efficacy of Everolimus (Afinitor). The latter is
November is always busier as I help spread awareness for 10th Nov (remembering that every day is 10th Nov on my site!). I also managed
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for Digestive Neuroendocrine Carcinoma
This ENETS guidance paper, developed by a multidisciplinary working group, provides up-to-date and practical advice on the diagnosis and management of digestive neuroendocrine carcinoma, based
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastric neuroendocrine tumours (NETs) G1–G3
The ENETS 2023 guideline for gNETs are combined with the guidelines for Duodenal NET (dNET) due to their close relationship in anatomical terms. Gastric neuroendocrine
A cup of tea
I would also mention those who contributed to my “Tea Fund” which resides on PayPal. You don’t need a PayPal account as you can select a card but don’t forget to select the number of units first (i.e. 1 = £4, 2 = £8, 3 = £12, and so on), plus further on, tick a button to NOT create a PayPal account if you don’t need one. Clearly, if you have a PayPal account, the process is much simpler
Through your generosity, I am able to keep my sites running and provide various services for you. I have some ideas for 2023 but they are not detailed enough to make announcements yet.
This screenshot is from every single post on my website and depending on which machine you are using, it will either be top right of the post or at the bottom (my posts are often long, so scroll down!)